The FDA’s medical device arm released its strategic priorities for the year, saying it plans to focus on 4 areas.
The watchdog agency’s Center for Devices & Radiological Health said it plans to concentrate on fully implementing a "total product life cycle approach," enhance its internal and external communication and transparency, strengthen its workforce, and "proactively facilitate innovation."